The challenge of antiretroviral drug resistance in HIV-1-infected children.
作者信息
Shafer Robert W
出版信息
J Pediatr (Rio J). 2009 Mar-Apr;85(2):91-4. doi: 10.2223/JPED.1894.
Abstract
摘要
相似文献
1
The challenge of antiretroviral drug resistance in HIV-1-infected children.
J Pediatr (Rio J). 2009 Mar-Apr;85(2):91-4. doi: 10.2223/JPED.1894.
2
HIV drug resistance in HIV-infected children.
J Pediatr (Rio J). 2009 Mar-Apr;85(2):94-6. doi: 10.2223/JPED.1895.
3
Antiretroviral therapy in HIV-infected infants and children.
Pediatr Infect Dis J. 2010 Apr;29(4):360-3. doi: 10.1097/INF.0b013e3181d616d8.
4
High frequency of antiretroviral drug resistance among HIV-infected adults receiving first-line highly active antiretroviral therapy in N'Djamena, Chad.
Clin Infect Dis. 2009 Jul 1;49(1):155-9. doi: 10.1086/599611.
5
Emtricitabine compared with lamivudine may preserve future therapeutic options in HIV-1-infected children.
J Antimicrob Chemother. 2013 Nov;68(11):2694-5. doi: 10.1093/jac/dkt215. Epub 2013 Jun 5.
6
HIV drug resistance and you. Resistance testing in experienced patients. Considerations when changing drugs.
Posit Aware. 2006 Winter;Spec No:17-22.
7
Antiretroviral Drug Resistance Among Children and Youth in the United States With Perinatal HIV.
Clin Infect Dis. 2016 Jul 1;63(1):133-137. doi: 10.1093/cid/ciw213. Epub 2016 Apr 7.
8
Incidence and predictors of antiretroviral resistance in perinatally HIV-1 infected children and adolescents.
J Infect. 2016 Mar;72(3):353-61. doi: 10.1016/j.jinf.2015.12.005. Epub 2015 Dec 19.
9
[Flexibility in avoiding resistance].
Pharm Unserer Zeit. 2004;33(5):349. doi: 10.1002/pauz.200490096.
10
Changing transmission fitness of drug-resistant human immunodeficiency virus against a background of evolving antiretroviral therapy.
J Infect Dis. 2003 Oct 15;188(8):1258; author reply 1258-9. doi: 10.1086/378679.
本文引用的文献
1
Diversity and prevalence of antiretroviral genotypic resistance mutations among HIV-1-infected children.
J Pediatr (Rio J). 2009 Mar-Apr;85(2):104-9. doi: 10.2223/JPED.1877.
2
Evaluation of prenatal care at basic health units in the city of Sao Paulo.
Rev Lat Am Enfermagem. 2008 Nov-Dec;16(6):986-92. doi: 10.1590/s0104-11692008000600008.
3
Early antiretroviral therapy and mortality among HIV-infected infants.
N Engl J Med. 2008 Nov 20;359(21):2233-44. doi: 10.1056/NEJMoa0800971.
4
Distinct resistance mutation and polymorphism acquisition in HIV-1 protease of subtypes B and F1 from children and adult patients under virological failure.
Infect Genet Evol. 2009 Jan;9(1):62-70. doi: 10.1016/j.meegid.2008.10.002. Epub 2008 Oct 17.
5
HIV-1 drug resistance mutations: an updated framework for the second decade of HAART.
AIDS Rev. 2008 Apr-Jun;10(2):67-84.
6
Prevalence of HIV type 1 drug resistance mutations in treatment-naïve and experienced patients from resource-limited settings with universal access to antiretroviral therapy: a survey in two small Brazilian cities.
Mem Inst Oswaldo Cruz. 2008 Mar;103(2):143-9. doi: 10.1590/s0074-02762008000200004.
7
HIV type 1 pol gene diversity and antiretroviral drug resistance mutations in Santos, Brazil.
AIDS Res Hum Retroviruses. 2008 Mar;24(3):347-53. doi: 10.1089/aid.2007.0203.
8
Monitoring effectiveness of programmes to prevent mother-to-child HIV transmission in lower-income countries.
Bull World Health Organ. 2008 Jan;86(1):57-62. doi: 10.2471/blt.07.043117.
9
High frequency of primary mutations associated with antiretroviral drug resistance in recently diagnosed HIV-infected children.
Antivir Ther. 2007;12(7):1133-7.
10
Antiretroviral resistance in individuals presenting therapeutic failure and subtypes of the human immunodeficiency virus type 1 in the Northeast Region of Brazil.
Mem Inst Oswaldo Cruz. 2007 Nov;102(7):785-92. doi: 10.1590/s0074-02762007005000109. Epub 2007 Dec 11.
Zotero 插件